blog - Hemanext

Hemanext Inc. Announces a Significant Milestone with FDA Marketing Authorization for Hemanext ONE®, Hemanext’s Innovative Red Blood Cell (RBC) Processing and Storage System

Hemanext ONE has been granted marketing authorization for commercial distribution via the De Novo process by the U.S. Food and Drug Administration (FDA) LEXINGTON, Mass., September 21, 2023, –Hemanext Inc., a leading innovator in blood processing, storage, and...

Hemanext Announces Founder Martin Cannon’s Retirement, Appoints Andrew Dunham as CEO, and Raises Funding for Growth

Hemanext, Press Release

LEXINGTON, Mass., September 18, 2023, – Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, marks a significant turning point in its history as the company announces the retirement of its founder, Martin Cannon. Simultaneously,...

Hemanext Announces Membership in European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)

Hemanext, Press Release

LEXINGTON, Mass., July 5, 2023, – Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, today announced its membership in the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), the region’s premier trade...

Hemanext Announces a Strategic Partnership and Investment from Vitalant

Hemanext, Press Release

Partnership to include research and development at Vitalant Innovation Center LEXINGTON, Mass., June 7, 2023, –Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, today announced a new partnership with Vitalant, one of the...

Hemanext Partners with Sickle Cell Disease Association of America and OneBlood to Support Blood Drive in Miami Gardens

Hemanext, Press Release, SCDAA

NFL Linebacker, Markus Golden Joins Forces for an Inspiring #Donate4Diversity Blood Drive on Saturday, April 1, 2023, at Walmart Supercenter parking lot, 19501 NW 27th Ave, Miami Gardens, FL LEXINGTON, Mass., March 31, 2023, – Sickle Cell Disease Association of...

Hemanext Continues European Rollout of Hemanext ONE® RBC Processing and Storage System

Hemanext, Press Release

Groundbreaking technology to be deployed to transfuse thalassemia patients in Italy and acute bleeding burn patients in Norway LEXINGTON, Mass., May 25, 2023, –Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, today announced...

Hemanext Partners with the Miami Chapter of the Sickle Cell Disease Association of America to Support Local Sickle Cell Disease Community

News, Press Release, SCDAA

Partnership Will Expand to Include Educational and Donation Event with OneBlood LEXINGTON, Mass., January 17, 2023, – Sickle Cell Disease Association of America, Inc. (SCDAA) and Hemanext Inc., a leading innovator in blood processing, storage, and transfusion...

Hemanext Announces Close of Series B Equity Funding Round

Press Release, Hemanext

Raises $18 Million in New Equity Financing Appoints Healthcare Luminary Dr. Ismail Kola to Board of Directors, Adding Clinical Development Expertise Progresses European Commercial Launch with Rollout to Key Distributors and Leading Hospitals and Blood Centers ...

European Patients Have Begun Receiving Transfusions with Hemanext ONE® RBC Processing and Storage System

Press Release, Hemanext

LEXINGTON, Mass., September 7, 2022, PR NEWSWIRE – Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, today announced that it has initiated the rollout of its Hemanext ONE® RBC (Red Blood Cell) Processing and Storage System in...

Hemanext Announces Publication of Hypoxic Blood Storage Study in Blood Advances

Hemanext, Press Release

Research shows that hypoxic storage preserves faster oxygen unloading from red blood cells compared to standard conditions.1 PRESS RELEASE – LEXINGTON, Mass., August 5, 2022 – (PR.com) – Hemanext Inc. Hypoxic storage preserves faster oxygen unloading from red blood...

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

YOU ARE ABOUT TO EXIT A US HEMANEXT CORPORATE WEBSITE FOR A GLOBAL HEMANEXT ONE PRODUCT WEBSITE

Recent Posts